临床外科杂志 ›› 2019, Vol. 27 ›› Issue (12): 1094-1098.doi: 10.3969/j.issn.1005-6483.2019.12.026

• • 上一篇    下一篇

胰腺神经内分泌肿瘤综合诊治进展

  

  1. 100191 北京大学第三医院普通外科 
  • 出版日期:2019-12-20 发布日期:2019-12-20
  • 通讯作者: 原春辉,Email:ychdoctor@163.com
  • 基金资助:
    国家自然科学基金资助项目(81672862)

Evolution of comprehensive diagnosis and treatment strategies for pancreatic neuroendocrine neoplasms

  1. Department of General Surgery,Peking University Third Hospital,Beijing 100191,China
  • Online:2019-12-20 Published:2019-12-20

摘要: 胰腺神经内分泌肿瘤(pancreatic neuroendocrine neoplasms,pNENs)是一类起源于胰腺神经内分泌细胞较罕见的异质性胰腺肿瘤,大多数为散发性,病因和具体发病机制尚不明确,近年发病率逐渐上升。根据是否伴有全身性内分泌症状可分为功能性和非功能性两类,大多数pNENs为非功能性,常以腹腔脏器的占位性改变为首发症状,肝脏是最常见的转移部位。准确的病理分级和分期对于确定适当的治疗方法至关重要。手术是唯一根治的方法,放化疗、靶向治疗、免疫治疗等全身性的治疗发挥越来越重要的作用。对于存在远端转移或晚期病人,其治疗的目标是改善症状,延长生存期,这通常需要多学科合作,确定最佳治疗方案,本文阐述对pNENs综合诊治方法的进展。

关键词: 胰腺神经内分泌肿瘤, 诊治, 进展

Abstract: Pancreatic neuroendocrine Neoplasms(pNENs)are a class of heterogeneous pancreatic tumors that originate from the pancreatic neuroendocrine cells.Most of them are sporadic,and the etiology and specific pathogenesis are still unclear.The incidence rate has gradually increased in recent years.According to whether it is accompanied by systemic endocrine symptoms,it can be divided into functional and nonfunctional.Most pNENs are non-functional,and often take the space-occupying change of abdominal organs as the first symptom.The liver is the most common metastatic site.Accurate pathological grading and staging are critical to determining the appropriate treatment.Surgery is the only cure,and systemic treatments such as radiotherapy,targeted therapy,and immunotherapy play an increasingly important role.For patients with distant metastases or advanced patients,the goal of treatment is to improve symptoms and prolong survival,which often requires multidisciplinary collaboration to determine the optimal treatment.This article describes the gradual recognition of pNENs as a rare tumor and the evolution of comprehensive diagnosis and treatment methods.

Key words: pancreatic neuroendocrine neoplasms, diagnosis and treatment, progression

[1] 顾岩, 杨建军, 宋致成等. 腹壁疝组织结构分离技术的进展和改革[J]. 临床外科杂志, 2019, 27(9): 739-742.
[2] 吴开明, 姚龙, 康宁宁等. 进展期食管癌微创治疗术后远期疗效及预后因素分析[J]. 临床外科杂志, 2019, 27(7): 558-561.
[3] 李子禹, 薛侃. 胃癌外科诊疗有感[J]. 临床外科杂志, 2019, 27(5): 361-362.
[4] 黄丽丹, 周子筌, 刘莉, 付涛, 于红刚, 朱旭. 血清酶学指标对结直肠癌病人预后的预测价值[J]. 临床外科杂志, 2019, 27(12): 1044-1047.
[5] 孙展, 韩斐, 罗凡砚, 陈育斌. 杂交手术治疗Stanford A型主动脉夹层的研究进展[J]. 临床外科杂志, 2019, 27(11): 925-927.
[6] 孟庆友, 赵彬. 复杂腹主动脉夹层动脉瘤腔内治疗的现状及进展[J]. 临床外科杂志, 2019, 27(11): 928-930.
[7] 朱旭, 刘莉, 于红刚. 炎症相关指标与结直肠癌预后的关系[J]. 临床外科杂志, 2019, 27(10): 873-875.
[8] 刘魏华, 舒凯. 面肌痉挛的研究现状及展望[J]. 临床外科杂志, 2019, 27(10): 907-909.
[9] 齐瑞兆, 史宪杰, 李志伟, 赵新, 王胜智, 刘庆艳, 郑扬, 张鹰, 朱晓雅, 常伟华, 常正尧, 张昆, 胡兴龙, 吴敏良. 门静脉高压症上消化道出血不同指南诊治共识外科部分的比较分析[J]. 临床外科杂志, 2019, 27(1): 62-66.
[10] 姬乐 刘涛 白浪 高永涛. 腹腔镜远端胃癌D2根治术对老年进展期胃癌病人CEA、DDC及血清HIF1α、MACC1的影响[J]. 临床外科杂志, 2018, 26(10): 739-743.
[11] 陶俊 王贵和. 局部进展期直肠癌新辅助放化疗后病理完全缓解的预测因素分析[J]. 临床外科杂志, 2018, 26(10): 756-759.
[12] 李宗光 韩竹 吉光荣. 腕管综合征的临床研究进展 [J]. 临床外科杂志, 2013, 21(5): 394-396.
[13] 李基业. 腹壁切口疝修补技术现状和趋势[J]. 临床外科杂志, 2012, 20(6): 377-377.
[14] 刘宝华. 结直肠癌外科治疗的国内外新进展[J]. 临床外科杂志, 2012, 20(4): 225-225.
[15] 张安平 刘宝华 李凡 童卫东 付涛 叶景旺. 新辅助放化疗联合手术治疗局部进展期低位直肠癌的疗效分析[J]. 临床外科杂志, 2012, 20(4): 234-234.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!